Efficacy and safety of a percutaneous right ventricular assist system

Ann Thorac Surg. 1996 Apr;61(4):1231-5. doi: 10.1016/0003-4975(96)00033-1.

Abstract

Background: Mechanical right ventricular assistance is necessary in the management of profound right ventricular failure resistant to medical therapy. Conventional right ventricular assistance requires a thoracotomy. We developed a technique for assisting the failing right ventricle without thoracotomy.

Methods: We implanted the percutaneous right ventricular assist system in animals to test its feasibility and safety. A feasibility study was performed in a right ventricular failure model using 12 open chest dogs, and we examined the effects of the system hemodynamically. Next, the system was implanted into 6 goats and driven for 2 to 8 days.

Results: Institution of the percutaneous right ventricular assist system revealed overall hemodynamic improvement on right ventricular failure in dogs. In the goat experiment, no animal died from cannula-related complications. No damage to the intracardiac structures and no pulmonary edema were seen. Plasma free hemoglobin concentration did not exceed 10 mg/dL.

Conclusions: The percutaneous right ventricular assist system is safe and effective in the management of right ventricular failure.

MeSH terms

  • Animals
  • Dogs
  • Evaluation Studies as Topic
  • Feasibility Studies
  • Female
  • Goats
  • Heart-Assist Devices* / adverse effects
  • Heart-Assist Devices* / statistics & numerical data
  • Hemodynamics
  • Safety
  • Ventricular Dysfunction, Right / physiopathology
  • Ventricular Dysfunction, Right / therapy